骨量减少是慢性肢体威胁性缺血患者术后2年生存的危险因素
单中心回顾性研究纳入273例接受血运重建的慢性肢体威胁性缺血(CLTI)患者,其中177例(64.8%)存在骨量减少。骨量减少患者2年术后生存率显著低于无骨量减少者(67.9% vs. 80.9%,P=0.0348),多因素分析显示骨量减少是2年术后生存的独立预后因素(HR 1.77,95%CI 1.02-3.08,P=0.0440)。
要点
- 骨量减少在CLTI血运重建患者中常见(64.8%),与2年生存率降低独立相关。
- 骨量减少患者2年生存率67.9%,显著低于无骨量减少者的80.9%。
- 选择血运重建方式时应将骨量减少纳入术前风险评估。
核心结论
- 骨量减少是CLTI患者血运重建术后2年生存的独立预后危险因素,尤其因骨量减少患者2年生存率较低,选择术式时应予以考虑。
研究设计与样本
- 单中心回顾性研究,纳入接受血运重建的CLTI患者273例,其中骨量减少177例(64.8%)。
主要发现
- 骨量减少患者2年术后生存率显著低于无骨量减少者(67.9% vs. 80.9%,P=0.0348)。
- 多因素分析显示年龄(HR 1.06,95%CI 1.03-1.10,P=0.0003)是2年术后生存的独立预后因素。
- 终末期肾病接受血液透析(HR 3.79,95%CI 2.22-6.47,P<0.0001)是2年术后生存的独立预后因素。
- 肌少症(HR 1.77,95%CI 1.02-3.08,P=0.0421)是2年术后生存的独立预后因素。
- 骨量减少(HR 1.77,95%CI 1.02-3.08,P=0.0440)是2年术后生存的独立预后因素。
临床怎么用
- 对CLTI患者进行血运重建术前评估时,应关注骨量减少情况,并将其纳入手术方式选择的考量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patients with chronic limb-threatening ischemia (CLTI) require revascularization. Current guidelines suggest careful consideration of patient risks prior to selecting the most appropriate approach to treatment. This study aimed to determine the impact of osteopenia as a prognostic factor in patients with CLTI. METHODS: This single-center retrospective study included patients with CLTI who underwent revascularization. The primary endpoint was 2-year postoperative survival. The secondary endpoint was 2-year amputation-free survival and limb salvage rates. RESULTS: Of 273 patients, 177 (64.8%) had osteopenia. Patients with osteopenia had a significantly lower 2-year postoperative survival than patients without osteopenia (67.9% vs. 80.9%, P = 0.0348). Multivariate analysis revealed that age (hazard ratio (HR): 1.06, 95% confidence interval (CI): 1.03-1.10, P = 0.0003), end-stage renal disease on hemodialysis (HR: 3.79, 95% CI: 2.22-6.47, P < 0.0001), sarcopenia (HR: 1.77, 95% CI: 1.02-3.08, P = 0.0421), and osteopenia (HR: 1.77, 95% CI: 1.02-3.08, P = 0.0440) were independent prognostic factors for 2-year postoperative survival in patients with CLTI. In particular, patients with osteopenia had a significantly lower 2-year survival rate after revascularization than patients without osteopenia (67.9% vs. 80.9%, P = 0.0348). CONCLUSION: Osteopenia is an independent prognostic risk factor in patients with CLTI and should be considered when choosing procedures, particularly as the 2-year survival rate of patients with osteopenia is low.
引用
- Kinoshita G, Matsubara Y, Ueno K, et al. Osteopenia is a Risk Factor for 2-year Postoperative Survival in Patients with Chronic Limb-Threatening Ischemia. Ann Vasc Surg. 2025. PMID: 40712804. doi:10.1016/j.avsg.2025.07.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。